Autosomal dominant inherited non-syndromic sensorineural hearing impairment : phenotype and genotype correlations of DFNA2-DFNA13-DFNA14-DFNA21 by Kunst, H.P.M.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
AUTOSOMAL DOMINANT INHERITED 
NON-SYNDROMIC SENSORINEURAL 
HEARING IMPAIRMENT
PHENOTYPE AND GENOTYPE CORRELATIONS OF 
DFNA2 -  DFNA13 -  DFNA14 -  DFNA21
H.P.M. Kunst
Druk: Print Partners Ipskamp, Enschede, the Netherlands
Cover: Reprinted with permission from: Doyle D, Cabral J, Pfuetzner R, Kuo A, Gulbis 
J, Cohen S, Chait B, MacKinnon R. The structure of the potassium channel: molecular 
basis of K+ conduction and selectivity. Science 1998; 280: 69-77. Copyright 1998 
American Association for the Advancement of Science.
Copyright © 1999
All rights reserved. No part of this publication may be reproduced, stored in a retrieval 
system, or transmitted in any form by any means, electronic, mechanical, photocopying, 
or otherwise, without written permission from the copyright owners.
CIP-gegevens koninklijke bibliotheek, Den Haag 
Kunst H.P.M.
Autosomal dominant inherited non-syndromic sensorineural hearing impairment 
Proefschrift Katholieke Universiteit Nijmegen
- Met literatuuropgave - Met samenvatting in het Nederlands 
ISBN 90-9013271-6
Autosomal dominant inherited non-syndromic 
sensorineural hearing impairment
PHENOTYPE AND GENOTYPE CORRELATIONS OF 
DFNA2 -  DFNA13 -  DFNA14 -  DFNA21
Samenvatting
Een wetenschappelijke proeve 
op het gebied van 
de Medische Wetenschappen
PROEFSCHRIFT
Ter verkrijging van de graad van doctor 
aan de Katholieke Universiteit Nijmegen, 
volgens besluit van het College van Decanen 
in het openbaar te verdedigen 
op woensdag 8 december 1999 





Promotor: Prof.dr. C.W.R.J. Cremers
Co-promotor: Dr. G. Van Camp (Universitaire Instelling Antwerpen)
Dr. H.A.M. Marres 
Manuscriptcommissie: Prof.dr. H.G. Brunner
Prof.dr. G.W.A.M. Padberg 
Prof.dr. C.H. van Os
This study was supported by grants from The Heinsius Houbolt Fund and The Nijmegen ORL 
Research Fund.
Publication was supported by: ABN-AMRO, Astra Pharmaceutica BV, Beltone Nederland BV, 
Bloemendal Optiek, Carl Zeiss BV, Dimedico International BV, GN ReSound, Electro Medical 
Instruments, Entermed BV, Faazen Hoortoestellen BV, Garant Optiek, Glaxo Wellcome BV, 
Groeneveld Winkelbedrijven BV, L. de Haan Hoorapparaten, HAL Allergenen Laboratorium BV, 
Horen Hoortoestellen, It’s Medical, Kooij Optiek/ Hoortoestellen, Kuykhoven Adviesgroep, Van 
Maaren Opticien, Mediprof Medical Products, Nederlandse Vereniging voor Slechthorenden, 
ACM Ooms, Oticon Nederland BV, Philips Hearing Technologies BV, Phonak BV, Raadgevers 
Medische Beroepen, Reugebrink Opticien, Rhöne-Poulenc Rorer BV, Schering-Plough BV, Sluijs 
Hoortechniek, Smith & Nephew Nederland BV, SmithKline Beecham Farma BV, Sol De Wilt 
Amersfoort, Stichting Atze Spoor Fonds, Stöpler Instrumenten & Apparaten BV, UCB Pharma 
BV, Veenhuis Medical Audio BV.
CONTENTS
Chapter 1 Introduction
1.1 Autosomal dominant non-syndromic sensorineural 
hearing impairment
1.2 Review: Non-syndromic autosomal dominant sensorineural hearing 
loss: a new field of research
H. Kunst, H. Marres, G. Van Camp, C. Cremers 
Clinical Otolaryngology 1998;23:9-17
1.3 Review paper: Recent developments in genetic hearing impairment
G. Van Camp, P. Willems, H. Kunst, H. Marres, R. Smith 
Journal o f Audiological Medicine 1998;7(2):120-133
1.4 Review paper: Nonsyndromic autosomal dominant hearing 
impairment: ongoing phenotypical characterisation of genotypes 
S. Bom, H. Kunst, P. Huygen, F. Cremers, C.W.R.J. Cremers 
British Journal o f Audiology, in press
Chapter 2 High-frequency hearing impairment - DFNA2
2.1 Inherited nonsyndromic hearing loss. An audiovestibular 
study in a large family with autosomal dominant progressive 
hearing loss related to DFNA2
(Dutch family I)
H. Marres, M. van Ewijk, P. Huygen, H. Kunst, G. Van Camp,
P. Coucke, P. Willems, C. Cremers
Archives o f Otolaryngology and Head & Neck Surgery 1997;123:573-577
2.2 Nonsyndromic autosomal dominant progressive sensorineural 
hearing loss: Audiologic analysis of a pedigree linked to DFNA2 
(Dutch family II)
H. Kunst, H. Marres, P. Huygen, R. Ensink, G. Van Camp,
P. Van Hauwe, P. Coucke, P. Willems, C. Cremers 
The Laryngoscope 1998;108:74-80
2.3 Autosomal dominant non-syndromal progressive sensorineural 
hearing impairment: audiological evaluation of a Dutch DFNA2 
family
(Dutch family II)
H. Kunst, H. Marres, P. Huygen, P. Coucke, P. Willems, C. Cremers 
Whurr Publishers, London, Developments in Genetic Hearing 
Impairment 1998;98-100
2.4 Genotype-phenotype correlation in progressive non-syndromic 
sensorineural hearing impairment linked tot the DFNA2 region 
on chromosome 1p34
H. Kunst, R. Ensink, H. Marres, F. Declau, S. Smith, B. Djelantik, 
P. Huygen, F. Wuyts, G. Van Camp, P. Van de Heyning,
C. Cremers 
Submitted
Chapter 3 Mid-frequency hearing impairment -  
DFNA13 / DFNA21
3.1 The phenotype of DFNA13/COL11A2; non-syndromic autosomal 
dominant mid- and high-frequency sensorineural hearing 
impairment
H. Kunst, C. Huybrechts, H. Marres, P. Huygen, G. Van Camp,
C. Cremers
American Journal o f Otology, in press
3.2 Non-syndromic autosomal dominant progressive 
non-specific mid-frequency sensorineural hearing impairment with 
childhood to late adolescence onset (DFNA21)
H. Kunst, H. Marres, P. Huygen, G. van Duijnhoven, A. Krebsova, 
S. Van der Velde, A. Reis, F. Cremers, C. Cremers 
Clinical Otolaryngology, in press
Chapter 4 Low-frequency hearing impairment - DFNA14
4 Autosomal dominant non-syndromal low-frequency sensorineural
hearing impairment linked to chromosome 4p16 (Df NA14): statistical 
analysis of hearing threshold in relation to age and evaluation of 
vestibulo-ocular functions
H. Kunst, H. Marres, P. Huygen, G. Van Camp, F. Joosten,
C. Cremers
Audiology 1999;38:165-173.
Chapter 5 Discussion and conclusions




ANOVA Analysis of variance
ATI Annual threshold increase (dB/y)
DFN Deafness non-syndromic X-linked
DFNA Deafness non-syndromic autosomal dominant
DFNB Deafness non-syndromic autosomal recessive
HL Hearing Level
ISO International Organization for Standardization
LOD Logarithm of Odds
PTA Pure tone average (dB HL)
SD Standard Deviation





Autosomal dominant non-syndromic 
sensorineural hearing impairment
Introduction
The first insight that heredity could be the cause of deafness appeared in the second 
edition of Politzer's Lehrbuch der Ohrenheilkunde published in 1887 . Direct or dominant 
inheritance was distinguished from indirect or recessive inheritance. Politzer based these 
conclusions on the work by another German author, Hartmann . Prior to this, Wilde 
(1853), Liebreich (1861) and Uchermann (1869) had found evidence that hearing 
impairment and deafness could be hereditary3-5.
The first descriptions of syndromes with hearing impairment or deafness appeared in the
4 6
19th century. Examples of these are the Usher syndrome ’ , the branchio-oto-renal
7 8 9 10syndrome , Pendred's syndrome , the Treacher Collins syndrome - and osteogenesis 
imperfecta tarda11.
Although the majority of hereditary hearing impairments are non-syndromic, most attention 
has been paid to syndromic hearing disorders, because they can be differentiated on the 
basis of the associated characteristics. Similarly, congenital forms of deafness have 
received more attention in the past than late-onset hearing impairments. The standard
textbook by George Fraser ‘The Causes of Profound Childhood Deafness’ published in
121976 is a case in point . Similarly, the standard cataloguizing work ‘Genetic and Metabolic 
Deafness’ by Konigsmark and Gorlin (also published in 1976) illustrates the steady
13increase in knowledge about hereditary syndromes with hearing impairment .
With the introduction of the audiometer in the late nineteen thirties it became easier to 
describe and differentiate non-syndromic forms of hearing impairment. Nevertheless, 
publications on families with non-syndromic autosomal dominant hearing impairment did 
not appear until the nineteen fifties.
Nowadays, approximately 1/1000 newborns have a major hearing impairment, i.e. with
14 15is probably inherited ’ . The mode of inheritance is autosomal recessive in 70%-80%,
autosomal dominant in 20%-30% and X-linked in 1%-2%14-16. Mitochondrial inherited
16deafness has also been described recently . In approximately 75% of the hereditary 
cases, no other stigmata related to sensorineural hearing impairment (SNHI) can be
15 17recognized ’ ; these types of hearing impairment are classified as non-syndromic.
The above-mentioned data are mostly related to profound early childhood deafness 
(prelingual phase). In the majority of autosomal dominant cases of hearing impairment, 
the age of onset is after early childhood (postlingual phase). The prevalence of postlingual 
deafness in western Europeans, with an average hearing threshold of >25 dB, is 
approximately 1 % in young adults, about 10% up to the age of 60 and almost 50% at the
14age of 80 . We do not know what proportion has a hereditary cause, and what the 
prevalence is of the different modes of inheritance of hereditary postlingual hearing 
impairment. It is most likely a multifactorial disease in many cases, where genetic as well 
as environmental factors are involved.
A number of families with hereditary monogenetically determined postlingual hearing
17impairment has been described in the literature . It has been found that the majority has 
a dominant pattern of inheritance and that the hearing impairment is progressive. 
Autosomal recessive non-syndromic disorders are often characterised by severe to
profound, non-progressive deafness, with a fairly consistent audiogram and a prelingual
18age of onset . Autosomal dominant hearing impairment generally seems to be milder and
18progressive; the onset is usually postlingual and the expression is variable .
Also our studies have shown that autosomal dominant forms of hearing impairment are 
mostly mild in the initial phase. There is usually obvious progression, which can
14bilateral hearing thresholds of 80 dB or more . In at least half of these cases, the cause
sometimes be fully (or partially) ascribed to presbyacusis. We have also observed obvious 
intrafamily and interfamily variability in expression.
Various types of hereditary non-syndromic sensorineural hearing impairment have been 
clinically distinguished on the basis of the mode of transmission, age of onset, severity, 
type of audiogram and progressivity.
The severity of the hearing impairment is expressed in decibel hearing level (dB HL) in the 
best ear. The average threshold at 500, 1000, 2000 and 4000 Hz is expressed as the pure
19tone average (PTA). Four grades of hearing impairment are distinguished :
* Mild: PTA <40 dB
* Moderate: PTA 40 dB - 70 dB
* Severe: PTA 70 dB - 95 dB
* Profound: PTA > 95 dB or more
Another characteristic that contributes to making a clinical distinction between various 
forms of hearing impairment is the shape of the audiogram, as described by Konigsmark
13 17and Gorlin and Gorlin et al. . The clinical review in Chapter 1.2 gives an overview of the 
major types of audiograms.
Owing to the introduction of increasingly more powerful gene-linkage techniques in the 
nineteen eighties, it has become possible to localise the locus on the genome in families 
with autosomal dominant hearing impairment (with a preference to 15 or more affected 
family members). In this way, 'clinically similar' forms of hereditary hearing loss can be 
distinguished on the basis of their genotype and this facilitates exact description of the 
corresponding phenotypes.
Genetic study
At present, an affected gene can be identified in two ways: by functional cloning or by 
positional cloning. In the case of functional cloning, the defective protein is known. With 
the aid of this defective protein, the defect can be detected on a genetic level. In the case 
of positional cloning, or reverse genetics, the defective protein is unknown. Positional 
cloning is the only method suitable for identifying the genes responsible for non-syndromic 
deafness. As it is a complicated and time-consuming method, only a few genes have been 
identified, but the numbers have been increasing steadily since 1997 (see Tables 2 to 4). 
Positional cloning comprises three steps: (i) the defective gene is localised, (ii) this gene 
is isolated and (iii) the defective protein is traced. The gene is localised by means of 
linkage analysis in affected families, with 200 to 300 polymorphic DNA markers 
(microsatellites) spread over the genome at given locations. The latter is also known as 
genome search. Computer programmes are used to calculate the probability that a marker 
and the defective gene cosegregate. This probability is expressed by a LOD score 
(logarithm of odds). A LOD score of above 3 is generally accepted to be a proof of linkage. 
In that case the linked genetic markers must be located in the same region as the disease 
gene. Various techniques can be used to isolate the gene, then attempts can be made to 
detect the mutation within this gene. Once the mutation is known, the third step is to obtain 
stuctural and functional information about the protein produced by the gene, which causes 
the disease80.
Current status of gene localisation for non-syndromic hearing impairment
Since 1992, considerable progress has been made in the field of molecular genetic
studies on hereditary sensorineural hearing impairment thanks to improved methods to 
investigate DNA. It has recently become possible to make genetic diagnoses based on 
molecular tests in some cases. This is important because different genotypes might lie 
behind (strikingly) similar phenotypes.
Table 1: Eight clinical types of autosomal dominant non-syndromic SNHI and corresponding loci, 
according to Gorlin et al. (1995)17
Clinical type Locus
1 Congenital severe SNHI
2 Congenital low-frequency SNHI DFNA6/DFNA14a
3 Progressive low-frequency SNHI DFNA1
with childhood onset
4 Mid-frequency SNHI DFNA8 / 12a; DFNA13a,b; DFNA21a,c
5 Progressive SNHI DFNA2a, DFNA5
6 Progressive mixed hearing impairment
7 Unilateral SNHI
8 Progressive vestibulo-cochlear DFNA9a
dysfunction and SNHI
a categorized by author; b Dutch family also combined with high-frequency SNHI; c non­
specific







DFNA1 5q31 199220 HDIA1 199721
DFNA2 1p34 199422 GJB3(Cx31),KCNQ4 199923,24
DFNA3 13q12 199425 GJB2(CX26) 199826
DFNA4 19q13 199527 - -
DFNA5 7p15 199528 DFNA5 199829
DFNA6 4p16.3 199530 - -
DFNA7 1q21-q23 199531 - -
DFNA8/DFNA12 11q22-24 199532,33 TECTA 199834
DFNA9 14q12-q13 199635 COCH 199836
DFNA10 6q22-q23 199637 - -
DFNA11 11q12.3-q21 199638 MYO7A 199739
DFNA13 6p21-p22 199740 COL11A2 199941
DFNA14 4p16.3 199742 - -
DFNA15 5q31 199843 POU4F3 199843
DFNA16 2q24 199844 - -
DFNA17 22q 199845 - -
DFNA18 3q22 199846 - -
DFNA19 10 199847 - -
DFNA20 reserved - - -
DFNA21 6p21 199948 - -
DFNA22 reserved - - -
DFNA23 reserved - - -
DFNA24 reserved - - -
DFNA25 reserved - - -
DFNA26a 5p11 - - -
DFNA27 reserved - - -
DFNA28 reserved - - -
a unpublished (Smith et al.)
Support for this notion can be found in autosomal dominant non-syndromic sensorineural 
hearing impairment: until recently only eight types could be distinguished clinically (Table
171) , while nowadays 28 different loci are known to be responsible for autosomal dominant 
non-syndromic hearing impairment (genotypes) (Table 2). The locus on a chromosome 
which harbours a gene that causes non-syndromic autosomal dominant hearing 
impairment, is specified by the prefix DFNA. Non-syndromic autosomal recessive 
hearing impairment carries the prefix DFNB. Table 3 gives an overview of 26 known 
DFNB regions. It is expected that the number of autosomal dominant types (DFNA1-28)
may increase to above the present number , .14 81







DFNB1 13q12 199449 GJB2 (CX26) 199750
DFNB2 11q13.5 199451 MYO7A 199752’53
DFNB3 17p11.2-q12 199554 MYO15A 199855
DFNB4 7q31 199556 PDS 199857
DFNB5 14q12 199558 - -
DFNB6 3p14-p21 199559 - -
DFNB7 9q13-q21 199560 - -
DFNB8 21q22 199661 - -
DFNB9 2p22-p23 199662 OTOF 199963
DFNB10 21q22.3 199664 - -
DFNB11 9q13-q21 199665 - -
DFNB12 10q21-q22 199666 - -
DFNB13 7q34-36 199867 - -
DFNB14 7q31 199868 - -
DFNB15 3q21-q25 and 19p13 199769 - -
DFNB16 15q21-q22 199770 - -
DFNB17 7q31 199871 - -
DFNB18 11p14-15.1 199872 - -
DFNB19 18p11 1998 - -
DFNB20 11q25 199873 - -
DFNB21 11q 199974 TECTA 199974
DFNB22 reserved - - -
DFNB23a 10p11.2-q21 - - -
DFNB24a 11q23 - - -
DFNB25a 4p15.3-q12 - - -
DFNB26 reserved
a Unpublished (R. Smith et al.)






DFN1a Xq22 199575 DDP -
DFN2 Xq22 199676 - -
DFN3b Xq21.1 199577 POU3F4 199577
DFN4 Xp21.2 199478 - -
DFN5 Withdrawn - - -
DFN6 Xp22 199679 - -
DFN7 Withdrawn - - -
DFN8 Reserved - - -
a Later recognized as syndromic 
b Mixed hearing impairment
Table 4 shows an overview of the currently known X-linked forms of non-syndromic
hearing impairment (DFN). Two non-syndromic forms of mitochondrial hereditary hearing
82impairment are known .
All these data are available on-line via the Hereditary Hearing loss Homepage: 
http://dnalab-www.uia.ac.be/dnalab/hhh
Research questions
Until recently, little was known about autosomal dominant inherited hearing impairment. 
The lack of knowledge prompted the question and uncovered the need to probe this 
largely unexplored territory. The aim was to describe the phenotype of the hearing 
impairment within various families on the basis of the associated (but as yet unknown) 
genotype. For this purpose, descriptions of audiograms, statistical analyses of audiometric 
data and vestibular analyses were used. A second aim was to detect genetic loci that had 
not been described previously. The resulting phenotypic and genotypic descriptions are 
expected to aid (early) diagnosis and individual counselling.
Tracing families with autosomal dominant hearing impairment 
A small confined area as the Netherlands offer ideal circumstances to perform family
studies on autosomal dominant disorders, it was an obvious choice to make use of them 
in the study described in this thesis, which started in 1995.
For the gene-linkage studies, we sought the cooperation of the Medical Genetics 
Department (Dr. G. Van Camp) at the University of Antwerp. One of their chief themes 
was genetic research into hereditary hearing impairment. In a later phase of the study, all 
the known DFNA loci had been excluded in some of the families. It was therefore 
necessary for new genome searches to be made. For the gene-linkage in one family we 
cooperated with the Department Human Genetics (Dr. F. Cremers) at the University of 
Nijmegen.
In the period that autosomal dominantly inherited hearing impairment could only be 
described in terms of progression, severity, age of onset and the shape of the audiogram, 
three main types of autosomal dominant hearing impairment could be distinguished: high- 
frequency, mid-frequency and low-frequency hearing impairment. High-frequency hearing 
impairment is common and often with an unknown etiology. Mid-frequency and low- 
frequency hearing impairment is rare and are mostly related to genetic sensorineural 
hearing impairment. We selected families with high-frequency, mid-frequency and low- 
frequency hearing impairment, in order to increase the chance of encountering different 
genotypes.
Family studies
The research group contacted the family of suitable patients who visited the outpatient 
clinic of the Ear, Nose and Throat Department of the University Hospital Nijmegen after 
they expressed interest in participating in ongoing genetic studies. A pedigree was drawn 
up with affected and non-affected persons identified on the basis of (hetero)anamnesis.
If it appeared that there were at least fifteen potentially affected persons, the family study 
was continued. Written and verbal information was provided about the aim of the study.
Table 5: Items included in medical history





- History of otitis
- Use of ototoxic drugs
- Noise-induced trauma
- T rauma capitis/ meningitis
- Abnormalities on previous audiograms
- Maternal infections or drug use during pregnancy
- Icterus/asphyxia at birth
- Family history
- Occurrence of hearing impairment in partner and his/her family_____________________
A standardised anamnesis form (Table 5) was used to obtain data from the family 
members. Examinations were generally conducted on a Saturday at the ENT Department. 
This made the day into a welcome family reunion. Otological and audiovestibular tests 
were performed. Attention was also paid to abnormalities accompanying the hearing 
impairment, which might indicate a syndromic diagnosis.
Hearing impairment was considered to be present when the hearing threshold in the best 
ear was poorer than the P95 for the patient's age. The ISO 7029 method was followed to 
calculate the P95 threshold values for presbyacusis for each patient individually at each
83frequency in relation to the patient's age . This method is very similar to that reported by
84Robbinson and Sutton who presented a full account of the method . Detailed 
methodological descriptions of the audio-vestibular examination and the statistical 
analyses are given in each chapter for the various families. In cases with high-frequency 
hearing impairment, we expected that all the frequencies would be affected. The
audiogram of this type of hearing impairment usually follows the same pattern as that for 
presbyacusis. In cases with low-frequency and mid-frequency hearing impairment, it is 
unusual for all the frequencies to be affected. The hearing thresholds at some frequencies 
therefore lie within the ‘normal’ range for presbyacusis. Owing to wide interfamily variability 
in the shape of the audiograms, each family was evaluated separately to determine which 
frequencies were involved in making the diagnosis. If a non-hereditary cause was found 
for the perceptive hearing impairment, the subject in the family study was considered to 
be ‘provisionally non-affected’. On the basis of these findings the provisional phenotype 
of the disorder was described and gene-linkage studies were started. When gene-linkage 
was sufficiently positive, we could indicate which family members were probably carriers 
of the affected genotype. Then on the basis of the genotype, the phenotype was 
described (see next paragraph).
At the beginning of the study described in this thesis, very few genotypes were known. It 
could be expected that genotype searches would be conducted on the large families
oc 07
described previously in the literature, one example is DFNA5 - . One of the aims of this 
thesis was to describe the phenotype in a number of families on the basis of the genotype 
that first had to be detected.
Description of phenotypes
An adequate description of a phenotype can only be made in large families with many 
affected individuals. In order for the statistical analyses on the audiometric data to be 
reliable, a large number of audiograms is required. Obviously data from all genetically 
affected individuals should be included in the analyses. Characteristic audiological 
features in the description of a phenotype are: audiogram shape, age of onset, pure tone
average (PTA) in prelingual/ lingual transition phase (pre- or postlingual hearing 
impairment), progression (annual threshold increase in dB/y: ATI), age range in which a 
hearing aid will be needed. The penetrance of the defective gene must also be described.
Chapter 1 presents three review articles that describe the current situation in this research 
field. In the clinical review (Chapter 1.2 and Chapter 1.4), an overview is given of the 
phenotypes of the DFNA regions that were described extensively in the literature up to 
1999. The data for the other DFNA regions were insufficient to make a detailed 
phenotypic description.
Chapter 2 shows two Dutch families with high-frequency hearing impairment.
Chapter 3 describes two Dutch families with mid-frequency hearing impairment. 
Chapter 4 presents a Dutch family with low-frequency hearing impairment.
Loci are known for all of the studied families, including two new loci. However, not all 
associated genes have yet been identified. This thesis comprises a collection of articles 
on autosomal dominant sensorineural hearing impairment. It describes the various 
phenotypes on the bases of the recently discovered genotypes. We carefully selected 
families whose audiograms indicated the presence of a different phenotype and therefore 
possibly a new genotype. Patients were recruited with hearing impairment starting at the 
higher frequencies, the mid-frequencies and low-frequencies. The results of these studies 
are presented in separate chapters.
Chapter 5 presents the discussion and the conclusions.
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At the beginning of 1996 this Ph.D. project was started officially by the department of 
Otorhinolaryngology of the University of Nijmegen to trace and to describe the 
phenotype based on a yet to be detected genotype of families with non-syndromic 
autosomal dominant inherited hearing impairment. The Netherlands may be ideal to 
perform family studies with an autosomal dominant pattern of inheritance. At the start 
of this Ph.D. project only the loci DFNA1-3 were known. At the close of this Ph.D. thesis, 
3 years later, a further 25 (DFNA4-DFNA28) are known. This speedy progress reviewed 
in the introduction (Chapter 1) of this Ph.D. thesis. Not only did we list the different loci 
but we also tried to make a comparison possible between the different phenotypes. It 
became clear that a proper description of the corresponding phenotype was only 
available for a few genotypes.
In the following Chapters 2,3,4 the phenotype of five large families with an autosomal 
dominant inherited sensorineural hearing impairment is reported. Two families have been 
linked to DFNA2, one family has been linked to DFNA13, one to DFNA14 and one to 
DFNA21. The loci DFNA14 and DFNA21 were newly identified by this Ph.D. project. The 
loci DFNA2 and DFNA13 had been detected just before we had collected our family data 
for genetic-linkage studies.
Our aim was to study and describe the phenotype for the afore mentioned DFNA loci 
extensively. In the hands of the clinician this information would clearly enrich genetic 
counselling as it would allow him to provide more accurate answers to the questions
raised by patients, their parents or other family members.
Chapter 2 describes the phenotype of different DFNA2 families. High-frequency 
sensorineural hearing impairment, the most frequently found type of sensorineural 
hearing impairment is described. All families showed progression that could not be 
explained by ageing alone. In addition a possible congenital hearing impairment was 
suggested. The DFNA2 locus is the locus identified in, as yet, the largest number of 
families. This suggests this locus to be of major importance in dominantly inherited 
sensorineural hearing impairment. Only this year it was discovered that the DFNA2 
locus comprises not a single gene but at least 3 different genes. It appeared that we had 
been focussing on DFNA2 families with KCNQ4 mutations. These families show 
different phenotypes than the one found in the Indonesian DFNA2 family, which does 
not show a mutation in KCNQ4 gene. Also within the 5 KCNQ4 families some difference 
in phenotype was found depending on the type of disturbance of functional domains of 
the protein. KCNQ4 is a potassium channel present in the outer hair cells of the cochlea 
and at a lesser degree in the heart. It is thought to be responsible for K+ recycling in the 
cochlea. We hope it might be possible in the near future to correct the malfunction of 
the K+ channel by medication.
Two families suffering from mid-frequency sensorineural hearing impairment are 
described in Chapter 3. The first family showed linkage to DFNA13; this locus was 
previously described in an American family. In our family the shape of the audiogram 
was in most cases a combination of mid- and high-frequency sensorineural hearing 
impairment, resulting in an audiogram with a notch mostly at 4 kHz. The influence of 
presbyacusis resulted in a downsloping audiogram at an older age. The DFNA21 locus
is a newly identified one. We describe it as non-specific mid-frequency sensorineural 
hearing impairment since the U-shaped audiogram was not found in all young patients. 
Several young patients showed a flat audiogram. In this family, progression that could 
not be attributed to ageing, resulted in a down-sloping audiogram in the older family 
members.
DFNA14, the second new locus described in this thesis (Chapter 4), is responsible for 
a phenotype with low-frequency sensorineural hearing impairment. It is one of the 
phenotypes with only minor intra-familial variability. Progression of hearing impairment 
in the described family could be explained by ageing, resulting in a flat audiogram at first 
and later on in a down-sloping audiogram. Remarkably, this family showed major 
phenotypical resemblance to an American family with linkage to the DFNA6 locus. It 
seems a reasonable guess that in a family with low-frequency sensorineural hearing 
impairment without progression, either the DFNA6 or the DFNA14 locus can be 
involved.
For four of the five families, the genetic-linkage studies were performed by the Department 
of Human Genetics of the University of Antwerp (Dr. G. Van Camp, Dr. P.J. Willems). For 
the DFNA13 family the gene identification and the mutation analysis was performed by 
the Molecular Otolaryngology Research Laboratories, University of Iowa (Prof.dr. R. 
Smith). Genetic-linkage for the DFNA21 family has been performed by the Department 
of Human Genetics, University of Nijmegen (Dr. F. Cremers) and by the MDC- 
Mikrosatelliten Zentrum Berlin (Dr. A. Reis). Successful collaboration with these molecular 
research laboratories provided the opportunity to be the first to describe the phenotypes
of the hearing impairment disorders linked to DFNA13, DFNA14 and DFNA21
This Ph.D. project has succeeded within a relatively short lapse of time in reporting on 
novel clinical and molecular findings in cooperation with molecular research laboratories. 
Based on our clinical and genetic studies new genes and mutations have been found for 
the already known DFNA2 and DFNA13 loci and can be expected to be found in the near 
future for DFNA14 and DFNA21. It is remarkable that so many of the families with an 
autosomal dominant inherited hearing impairment recently studied are linked to new loci. 
We therefore expect that this new research field of genetics of hearing impairment will 
remain a challenging field of research for the coming years.
The number of hereditary syndromes including hearing impairment is still increasing and 
is now between 450 and 500. The number of non-syndromic types of genetic hearing 
impairment (DFN1-8, DFNA1-28, DFNB1-26 and the mitochondrial types) has increased 
over the last 5 years with about 50 newly recognised genetic types of hearing 
impairment. The recent experience is that the chance to encounter a new genotype 
when studying a new family with an autosomal dominant inherited hearing impairment 
is over 50%. This may be a prelude to the enormous genetic heterogeneity to be 
expected in the field of genetic non-syndromic hearing impairment.
The purpose of clinical and genetic family studies such as reported in this Ph.D. thesis 
is mainly to increase our knowledge on the various newly recognised types of genetic 
hearing impairment. By tracing the genes and their mutations we can begin to 
understand the crucial function of these genes in the inner ear. We hope to be able to
find a cure for or stabilise hearing impairment by achieving an understanding of the 
functioning of the inner ear on a molecular basis.
For patients and their families, the news is that genetic counselling for genetic hearing 
impairment will increasingly be based on mutation analysis. The description of the 
phenotypes may help their specialist to reach a correct clinical diagnosis based on 
mutation analysis. It also provides the opportunity to inform the patient in more detail 
about the underlying disorder and prognosis. In families with progressive hearing 
impairment with a late onset a genetic test may provide a presymptomatic diagnosis. Of 
course it should be evaluated whether such information has a place within the context 
of genetic counselling.
Most of the autosomal dominantly inherited non-syndromic types of hearing impairment, 
appear to show progressive hearing impairment, starting as mild to moderate hearing 
impairment in childhood, adolescence or even at a more advanced age. This is in strong 
contrast with the autosomal recessive inherited types which, in general, show stable, 
moderate to profound congenital or early-childhood hearing impairment. Mutation 
analysis (Cx26) for DFNB1 is already available in many hospitals. The percentage of 
children with DFNB1 among the children with an autosomal recessive type of inherited 
childhood deafness is so high in many countries (30%-50%) that this opportunity to 
reach a final genetic diagnosis for early childhood deafness has become clinical 
practice. This example shows how quickly scientific novelties in the field of genetic 
hearing impairment can be incorporated in clinical practice.
Discussie en conclusies
Begin 1996 werd dit promotie project officieel gestart aan de Keel-, Neus- en 
Oorheelkunde kliniek van het Academisch Ziekenhuis Nijmegen. De opzet was om het 
phenotype te beschrijven van families met autosomaal dominant overervende 
slechthorendheid op basis van een nog te vinden genotype. Nederland wordt gezien als 
een ideaal land om dergelijke studies uit te voeren. Toen deze studie werd opgestart 
waren slecht drie loci (DFNA1-3) bekend. Momenteel, 3 jaar na de aanvang van de studie, 
zijn reeds 25 andere loci opgespoord (DFNA4-28). Een overzicht van deze snelle 
ontwikkeling wordt gegeven in de introductie (Hoofdstuk 1). Wij hebben getracht om niet 
alleen een opsomming te geven van de verschillende loci maar ook om een vergelijking 
mogelijk te maken van de phenotypen. Het werd duidelijk dat slechts voor een klein aantal 
genotypen een goede beschrijving van het phenotype voorhanden was.
In de Hoofdstukken 2,3 en 4 wordt het phenotype beschreven van vijf grote families met 
autosomaal dominant overervende slechthorendheid. Twee families zijn gekoppeld aan 
DFNA2, 1 familie is gekoppeld aan DFNA13, 1 familie aan DFNA21 en 1 familie aan 
DFNA14. The loci DFNA14 en DFNA21 zijn nieuw gevonden loci. De loci DFNA2 en 
DFNA13 waren gevonden kort voor wij onze familie gegevens verzameld hadden.
Het doel was om de phenotypes van de bovengenoemde DFNA loci uitgebreid te 
bestuderen en beschrijven. Deze informatie zal, in handen van de clinicus, de 
genetische voorlichting verrijken, aangezien hij hierdoor meer accurate antwoorden zal 
kunnen geven op vragen gesteld door patiënten, hun ouders en andere familieleden.
In Hoofdstuk 2 wordt het phenotype beschreven van verscheidene DFNA2 families. Het 
betreft een hoge-tonen slechthorendheid, dit is de meest voorkomende vorm van 
gehoorverlies. In alle families werd een progressie van het gehoorverlies gevonden die 
niet verklaard kon worden op basis van alleen presbyacusis. In wisselende mate was 
er bovendien sprake van een mogelijk congenitaal gehoorverlies. De DFNA2 locus is 
de locus waarop, tot nu toe, het grootste aantal families is gekoppeld. Dit suggereert dat 
het waarschijnlijk een belangrijk gen herbergt, dat autosomaal dominant gehoorverlies 
veroorzaakt. Dit jaar werd ontdekt dat de DFNA2 locus niet 1 maar tenminste 3 
verschillende genen vertegenwoordigt. Het bleek dat wij ons met name gericht hadden 
op DFNA2 families met een defect in het KCNQ4 gen. Deze families tonen een ander 
phenotype dan dat van de Indonesische DFNA2 familie welke geen mutatie bezit in het 
KCNQ4 gen. Ook binnen de KCNQ4 families hebben wij enige verschillen in phenotype 
waargenomen, afhankelijk van het type verstoring van functionele domeinen van het 
proteïne. KCNQ4 is een kalium kanaal welk aanwezig is in de buitenste haarcellen van 
de cochlea en in mindere mate in het hart. Aangenomen wordt dat het verantwoordelijk 
is voor K+ recycling in de cochlea. Wij hopen dat het in de toekomst mogelijk zal worden 
om de malfunctie van het K+ kanaal medicamenteus te corrigeren.
Twee families met een perceptief midden-tonen gehoorverlies worden beschreven in 
Hoofdstuk 3. De eerste familie koppelde aan DFNA13; deze locus is eerder beschreven 
in een Amerikaanse familie. Het audiogram type in onze familie betrof in de meeste 
gevallen een combinatie van midden- en hoge-tonen perceptief verlies, hetgeen 
resulteerde in een notch bij 4 kHZ. Presbyacusis veroorzaakte op latere leeftijd een
aflopend audiogram. DFNA21 is een nieuw ontdekte locus. Het betreft een niet-specifiek 
midden-tonen perceptief verlies. Niet specifiek aangezien het midden-tonen verlies niet 
in alle jonge individuen werd terug gevonden; enkelen toonden een vlak audiogram. In 
deze familie werd progressie van het gehoorverlies waargenomen, die niet verklaard 
kon worden op basis van presbyacusis. Dit resulteert op oudere leeftijd in een aflopend 
audiogram.
DFNA14, de tweede nieuwe locus welke in deze thesis beschreven wordt is 
verantwoordelijk voor een lage-tonen gehoorverlies. Het is een phenotype met slechts 
een milde intra-familiaire variatie. De progressie van het gehoorverlies kon worden 
verklaard op basis van presbyacusis. Hierdoor ontstaat in eerste instantie een vlak en 
later een aflopend audiogram. Het is opvallend dat deze familie grote overeenkomsten 
vertoont met een Amerikaanse familie welke gekoppeld is aan DFNA6 . Het mag 
verondersteld worden dat in een familie met een lage-tonen gehoorverlies zonder 
progressie mogelijk of DFNA6 of DFNA14 verantwoordelijk is.
Voor vier van de vijf families werden de genetische studies verricht door de afdeling 
Medische Genetica van de Universitaire Instelling Antwerpen (Dr. G. Van Camp, Dr. P.J. 
Willems). De gen identificatie en mutatie analyse bij de DFNA13 familie werd verricht 
door de Molecular Otolaryngology Research Laboratories, University of Iowa (Prof.dr. 
R. Smith). Het gen-koppelings onderzoek bij de DFNA21 familie is verricht door de 
afdeling Antropogenetica van het Academisch Ziekenhuis Nijmegen (Dr. F. Cremers) 
en door het MDC-Mikrosatelliten Zentrum Berlin (Dr. A. Reis). De succesvolle 
samenwerking met deze genetische laboratoria heeft ons de mogelijkheid geboden om
als eerste het phenotype te beschrijven van gehoorverliezen veroorzaakt door DFNA13, 
DFNA14 en DFNA21.
Dit promotie project is erin geslaagd om in een relatief kort tijdsbestek een aantal 
nieuwe klinische en moleculaire bevindingen te beschrijven. Naar aanleiding van onze 
klinische en genetische studies zijn nieuwe genen en mutaties gevonden voor de reeds 
bekende loci DFNA2 en DFNA13. Verondersteld mag worden dat dit eveneens zal 
gelden voor DFNA14 en DFNA21. Het is een opvallende bevinding dat er veel families 
zijn met autosomaal dominant overervende slechthorendheid, die gekoppeld is aan een 
nieuwe locus. Het is dan ook de verwachting dat dit onderzoeksgebied de komende 
jaren nog volop in beweging zal blijven.
Het aantal erfelijke syndromen met gehoorverlies als kenmerk groeit nog steeds, 
momenteel zijn er tussen de 450 en 500 bekend. Het aantal niet syndromale typen van 
erfelijk gehoorverlies (DFN1-8, DFNA1-28, DFNB1-26 en de mitochondriële typen) is 
de laatste 5 jaar met ongeveer 50 toegenomen. De meest recente gedachte is, dat de 
kans om een nieuw genotype te vinden bij families lijdend aan erfelijk dominant 
gehoorverlies, ongeveer 50% bedraagt. Dit zou als een voorteken gezien kunnen 
worden van de grote heterogeniteit welke wij binnen de groep van erfelijke niet 
syndromale gehoorverliezen verwachten.
Het doel van klinische en genetische studies, die in deze thesis besproken worden is 
met name kennis verrijking op basis van nieuw gevonden typen van erfelijk 
gehoorverlies. Door de genen en de bijbehorende mutaties op te sporen kunnen wij
trachten de cruciale functie van deze genen te begrijpen. Door het functioneren van het 
binnenoor op een moleculaire basis te begrijpen, hopen wij dat er in de toekomst een 
therapie gevonden wordt of dat de progressie van gehoorverlies tot stilstand gebracht 
kan worden.
Het nieuws voor patiënten en hun families is dat de genetische voorlichting vaker 
gebaseerd zal gaan worden op mutatie analyse. De beschrijving van het phenotype kan 
de specialist helpen om een correcte klinische diagnose te bereiken gebaseerd op een 
mutatie analyse. Het biedt eveneens de mogelijkheid om de patiënt nauwkeuriger te 
informeren over de onderliggende ziekte en prognose. Bij families met een progressief 
gehoorverlies met een relatief hoge aanvangsleeftijd kan genetisch onderzoek leiden 
tot een presymptomatische diagnose. Natuurlijk zal geëvalueerd moeten worden of 
dergelijke informatie een plaats heeft binnen de genetische voorlichting.
De meeste autosomaal dominant overervende niet syndromale typen gehoorverlies 
blijken een progressie van gehoorverlies te tonen. Dit verlies begint vaak als een mild 
tot matig gehoorverlies op kinderleeftijd, tijdens adolescentie of zelfs later. Dit 
contrasteert sterk met de autosomaal recessief overervende typen, die over het 
algemeen een stabiel, matig tot ernstig gehoorverlies tonen, welk zich congenitaal of op 
kinderleeftijd manifesteert. Mutatie analyse (Cx26) voor DFNB1 is reeds voorhanden in 
vele ziekenhuizen. Het percentage kinderen met DFNB1, onder kinderen met een 
autosomaal recessief overervende vroegkinderlijke slechthorendheid is in veel landen 
hoog (30%-50%). In de dagelijkse praktijk kan het hierdoor nu reeds vaak mogelijk zijn 
om tot een definitieve genetische diagnose te komen bij dit type slechthorendheid. Dit
voorbeeld toont hoe snel nieuwe wetenschappelijke bevindingen op het gebied van de 
erfelijke slechthorendheid geïncorporeerd kunnen worden in de klinische praktijk.
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